Medicine guide

Adcetris 50 mg

As listed in the register: Adcetris 50 mg, poeder voor concentraat voor oplossing voor infusie

50 mg · poeder voor concentraat voor oplossing voor infusie

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Brentuximab Vedotin
Made by
Takeda Pharma A/S

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01FX05

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byTakeda Pharma A/S
Active substanceBrentuximab Vedotin
Used inCancer treatments and immune-system medicines
Strength50 mg
Formpoeder voor concentraat voor oplossing voor infusie
ClassificationL01FX05 · Cancer treatments and immune-system medicines
Routeintraveneus gebruik
Dispensing (as stated by the register)Uitsluitend recept
Name in the registerAdcetris 50 mg, poeder voor concentraat voor oplossing voor infusie
RVGEU/1/12/794

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).